XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Research and Development and License Agreements (Details Narrative)
£ in Thousands
3 Months Ended 9 Months Ended
Mar. 27, 2024
USD ($)
Jan. 02, 2024
USD ($)
Feb. 01, 2023
USD ($)
Jan. 31, 2023
USD ($)
Apr. 21, 2022
USD ($)
Mar. 09, 2022
USD ($)
Sep. 17, 2021
USD ($)
Mar. 19, 2018
USD ($)
Jun. 06, 2017
GBP (£)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Mar. 31, 2022
USD ($)
Aggregate milestone payments               $ 19,800,000     $ 150,000      
Research service fees payments $ 1,845,260 $ 343,467 $ 321,500 $ 81,500                    
Notice period for terminating                     90 days      
Nonrefundable fee                           $ 1,500,000
Research and development expense                   $ 1,143,396 $ 1,495,619 $ 4,712,765 $ 4,022,020  
License [Member]                            
Aggregate milestone payments                     300,000      
Med Pharm License Agreement [Member]                            
Aggregate milestone payments | £                 £ 1,150          
Lipocure Agreement [Member]                            
Research service fees payments     $ 1,286,000         150,000            
Research and development expense                   487,200 488,000 1,902,700 1,130,000  
Nanomerics Collaboration Agreement [Member]                            
Aggregate milestone payments           $ 5,500,000   $ 103,000,000            
Nanomerics Collaboration Agreement [Member] | Commercial Milestone [Member]                            
Aggregate milestone payments           112,500,000                
Amended Nanomerics License Agreement [Member]                            
Additional milestone payments           $ 999,999                
Amended Nanomerics License Agreement [Member] | Minimum [Member]                            
Profit share arrangement percentage           30.00%                
Percentage of royalties           5.00%                
Amended Nanomerics License Agreement [Member] | Maximum [Member]                            
Profit share arrangement percentage           40.00%                
Percentage of royalties           15.00%                
Nanomerics License Agreement [Member]                            
Upfront milestone payments             $ 200,000              
Milestone payments         $ 500,000                  
Nanomerics License Agreement [Member] | Minimum [Member]                            
Percentage of royalties             5.00%              
Nanomerics License Agreement [Member] | Maximum [Member]                            
Percentage of royalties             15.00%              
Yissum Research Agreement [Member]                            
Research service fees payments       $ 326,000                    
Research and development expense                   $ 85,867 $ 81,500 $ 257,600 $ 244,500